Related Experiment Videos
Determining antibiotic resistance in Helicobacter pylori
Sandra Hjalmarsson1, Maria Sjölund, Lars Engstrand
1Dept. of Medical Sciences, Section of Clinical Bacteriology, Box 552, SE-751 22, Uppsala, Sweden.
Expert Review of Molecular Diagnostics
|June 8, 2002
Summary
Antibiotic resistance in Helicobacter pylori is a major cause of treatment failure, particularly with clarithromycin. DNA-based methods show promise for replacing traditional tests in predicting antimicrobial resistance phenotypes.
Area of Science:
- Microbiology
- Genetics
- Clinical Medicine
Background:
- Antimicrobial resistance in Helicobacter pylori (H. pylori) is a significant clinical challenge, leading to treatment failures.
- Macrolide resistance, specifically to clarithromycin, is a primary concern as it is a key component of H. pylori eradication therapies.
Purpose of the Study:
- To explore the potential of DNA-based methods for predicting antimicrobial resistance in H. pylori.
- To assess the feasibility of these molecular techniques replacing traditional resistance determination methods.
Main Methods:
- Review of current and emerging molecular diagnostic techniques for H. pylori resistance.
- Analysis of the transition from traditional phenotypic resistance testing to genotypic methods.
Main Results:
- Traditional methods like disc diffusion and E-tests may be superseded by DNA-based approaches within five years.
- Molecular methods for predicting antimicrobial resistance phenotypes are currently available in research settings.
Conclusions:
- Rapid, reliable DNA-based assays for H. pylori resistance are advancing.
- Decreasing fabrication costs and development of user-friendly assays will likely establish DNA-based methods as crucial clinical tools for diagnosing resistant H. pylori strains.